Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Qatar Precision Medicine Institute/Qatar Genome Program is building the next generation of infrastructures to test the value of predictive genomics
Navigate the technology landscape in predictive genomics
Learn from global experts how genomics innovations are changing future of healthcare
Propel your predictive genomics research initiative forward using genotyping microarrays that can increase your confidence in the insights you uncover
White Paper: Preemptive Pharmacogenomics-investigating the relationship between genotype and drug response.
White Paper: Navigating the technology landscape for population-scale predictive genomics and exploring strategies for disease risk and drug response research.
Microarray technology enables the high-throughput analysis of genotyping, gene expression, and chromosome copy number variations and can be applied to various applications such as predictive genomics.
Hear from scientists in the field of predictive genomics as they discuss their respective clinical research focus with the aim of population-scale health management.
Bringing predictive genomics into a nationwide model: A spotlight on the Taiwan Precision Medicine Initiative
MADCaP: The First Large Pan-African GWAS Tackling Cancer Health Disparities in African Populations
Polygenic risk scores for coronary disease
Score one for predictive genomics as polygenic risk scoring advances
Read blog ›
Combining genomics and health record data for better health outcomes (FinnGen)
Read customer interview ›
Bringing predictive genomics into a nationwide model (Taiwan PMI)
What is the performance of polygenic risk scores in non-European groups?
Cancer Genomics: What We Can Learn from Africa
Accurate PGx testing: A market overview
Integrating preemptive pharmacogenomics into health care (UPitt)
The vision for preemptive pharmacogenomic screening for broad-based research
Preemptive pharmacogenomics: Covering markers relevant today and those that might be useful in the future
The influence of human genetics on SARS-CoV-2 infection risk: insights from the UK Biobank
Host Genetics with the new Axiom Human Genotyping SARS-CoV-2 Research Array
Biobanks, Phenotypes, and Population Variation: Revolution or Evolution in Complex Trait Genetics?
Improving Transplantation Success with Genotyping
Polygenic risk scores for coronary disease
Score one for predictive genomics as polygenic risk scoring advances
Read blog ›
Combining genomics and health record data for better health outcomes (FinnGen)
Read customer interview ›
Bringing predictive genomics into a nationwide model (Taiwan PMI)
What is the performance of polygenic risk scores in non-European groups?
Cancer Genomics: What We Can Learn from Africa
Accurate PGx testing: A market overview
Integrating preemptive pharmacogenomics into health care (UPitt)
The vision for preemptive pharmacogenomic screening for broad-based research
Preemptive pharmacogenomics: Covering markers relevant today and those that might be useful in the future
The influence of human genetics on SARS-CoV-2 infection risk: insights from the UK Biobank
Host Genetics with the new Axiom Human Genotyping SARS-CoV-2 Research Array
Biobanks, Phenotypes, and Population Variation: Revolution or Evolution in Complex Trait Genetics?
Improving Transplantation Success with Genotyping
The selection of publications and posters below focuses on large-scale predictive genomic studies citing the use of the Applied Biosystems Axiom whole-genome microarray platform.
Predictive Genomics blog series
Gain perspectives on the use and impact of predictive genomics in clinical research.
Axiom microarray solutions ›
As the platform choice for large-scale predictive genomics studies, explore the Axiom microarray portfolio to find your array of choice.
Technical Note: Imputation-aware microarrays offer more power than low-pass sequencing
For Research Use Only. Not for use in diagnostic procedures.